FDA approves Amgen’s small cell lung cancer drug



The United States Food and Drug Administration (FDA) said on Thursday it granted accelerated approval to tarlatamab, Amgen’s small cell lung cancer drug, also known as Imdelltra.”This application was …
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento